HDAC9 and hepatocellular carcinoma: The HDAC inhibitor SAHA also induces G1 cell cycle arrest and apoptosis in multidrug-resistant sarcoma, hepatocellular carcinoma, cholangiocarcinoma, and lymphoma cells, perhaps through alterations of cyclins and associated cycle-dependent kinases 28-30.